< Back to latest news & events


Celebrating Success in the Pharmaceuticals Industry: Jazz Pharmaceuticals Enters Deal With Redx

February 2024

HGF would like to congratulate Redx Pharmaceuticals on their recent deal with Jazz Pharmaceuticals concerning the global rights to Redx’s KRAS Inhibitor Program.

This partnership has the potential to provide innovative new cancer treatments that address a currently unmet medical need through the development of KRAS inhibitors.

Redx received a $10 million payment and is potentially entitled to up to a further £870 million of milestone payments. Additionally, Redx stands to receive royalties on product sales, should the collaboration give rise to a marketed drug product.

This deal confirms Redx’s reputation as a UK leader in the field of drug discovery and development.  Redx have a terrific track record of designing potential drug molecules.

At HGF, we take great pride in assisting Redx in obtaining strong, dynamic IP portfolios that protect their assets, and which play a crucial role in securing partnerships and driving innovation. We look forward to seeing the positive impact of this alliance and the potential breakthroughs it may bring.

Click the button below to find out more.

Latest updates

Medical 3D Technologies: From Scanning to Printing

When we think of 3D technologies, we often think of 3D printing, which, as discussed later, has seen rapid advances in recent years. However, a sometimes overlooked area of medical …

Read article

Opinion Piece: Unitary Patent and Unified Patent Court in Ireland

Intellectual Property (IP) is a core part of any business and particularly is a vital part of the strategic toolkit for any business that creates value through innovation and constant …

Read article

IP Ingredients Blog, Parts 11-20

Welcome to our blog series, IP Ingredients, created by our Food & Drink Team. This blog will explore the latest IP news, updates, and discussions in the food & drink …

Read article

EnteroBiotix Limited Secures £27m Financing Round to Advance Clinical Trials

We are pleased to congratulate EnteroBiotix, on their milestone in their journey towards revolutionising healthcare for patients battling gut-related ailments. The leading clinical-stage biotechnology company has successfully closed a £27 …

Read article
Event - 20th June 2024

Go:Tech Awards 2024 shortlist has been revealed

The shortlist has now been revealed for the Go:Tech 2024 awards, which will take place on the 20th June in London. We are delighted to be sponsoring the ‘Tech Start-Up …

Event details

HGF wins big at the Managing IP EMEA Awards Ceremony 2024

The Annual Managing IP Awards: EMEA Awards 2024 were announced last night, and HGF are proud to have won ‘Ireland Patent Prosecution Firm of the Year’ and ‘Netherlands Trademark Prosecution …

Read article